Rare Endocrine Disease Treatment Market Report

China Rare Endocrine Disease Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Oct 15, 2023
  • PAGES：231
  • REPORT CODE：GMM1856601
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Rare Endocrine Disease Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis

    • Ipsen

    • EMD Serono

    • Corcept Therapeutics

    • Amgen

    • Takeda

    • Eli Lilly

    • Teva

    • Novelion Therapeutics

    By Type:

    • Organic Compounds

    • Biologics

    By Application:

    • Retail Pharmacies

    • Hospital Pharmacies

    • Online Pharmacies

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Rare Endocrine Disease Treatment Market Overview 2018-2029

    • 1.1 China Rare Endocrine Disease Treatment Industry Development Overview

    • 1.2 China Rare Endocrine Disease Treatment Industry Development History

    • 1.3 China Rare Endocrine Disease Treatment Industry Market Size (2018-2029)

    • 1.4 China Rare Endocrine Disease Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Rare Endocrine Disease Treatment Production Volume, Production Value and Growth Rate of Organic Compounds (2018-2029)

      • 1.4.2 China Rare Endocrine Disease Treatment Production Volume, Production Value and Growth Rate of Biologics (2018-2029)

    • 1.5 China Rare Endocrine Disease Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Rare Endocrine Disease Treatment Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

      • 1.5.2 China Rare Endocrine Disease Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.3 China Rare Endocrine Disease Treatment Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • 1.6 China Rare Endocrine Disease Treatment Market Analysis by Region

      • 1.6.1 North China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Rare Endocrine Disease Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Rare Endocrine Disease Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Rare Endocrine Disease Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Rare Endocrine Disease Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Rare Endocrine Disease Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Rare Endocrine Disease Treatment Industry Development

    Chapter 3 Rare Endocrine Disease TreatmentIndustry Chain Analysis

    • 3.1 Rare Endocrine Disease Treatment Industry Chain

    • 3.2 Rare Endocrine Disease Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Rare Endocrine Disease Treatment Market

    • 3.3 Rare Endocrine Disease Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Rare Endocrine Disease Treatment Market

    Chapter 4 China Rare Endocrine Disease Treatment Market, by Type

    • 4.1 China Rare Endocrine Disease Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Rare Endocrine Disease Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Rare Endocrine Disease Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Rare Endocrine Disease Treatment Production Volume and Growth Rate of Organic Compounds

      • 4.5.2 China Rare Endocrine Disease Treatment Production Volume and Growth Rate of Biologics

    Chapter 5 China Rare Endocrine Disease Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Rare Endocrine Disease Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Rare Endocrine Disease Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Rare Endocrine Disease Treatment Market Size and Growth Rate of Retail Pharmacies

      • 5.5.2 China Rare Endocrine Disease Treatment Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.3 China Rare Endocrine Disease Treatment Market Size and Growth Rate of Online Pharmacies

    Chapter 6 China Rare Endocrine Disease Treatment Market, by Region

    • 6.1 China Rare Endocrine Disease Treatment Production Volume and Production Value, by Region

    • 6.2 China Rare Endocrine Disease Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Rare Endocrine Disease Treatment Market Analysis

    • 7.1 North China Rare Endocrine Disease Treatment Market, by Type

    • 7.2 North China Rare Endocrine Disease Treatment Market, by Application

    Chapter 8 Central China Rare Endocrine Disease Treatment Market Analysis

    • 8.1 Central China Rare Endocrine Disease Treatment Market, by Type

    • 8.2 Central China Rare Endocrine Disease Treatment Market, by Application

    Chapter 9 South China Rare Endocrine Disease Treatment Market Analysis

    • 9.1 South China Rare Endocrine Disease Treatment Market, by Type

    • 9.2 South China Rare Endocrine Disease Treatment Market, by Application

    Chapter 10 East China Rare Endocrine Disease Treatment Market Analysis

    • 10.1 East China Rare Endocrine Disease Treatment Market, by Type

    • 10.2 East China Rare Endocrine Disease Treatment Market, by Application

    Chapter 11 Northeast China Rare Endocrine Disease Treatment Market Analysis

    • 11.1 Northeast China Rare Endocrine Disease Treatment Market, by Type

    • 11.2 Northeast China Rare Endocrine Disease Treatment Market, by Application

    Chapter 12 Southwest China Rare Endocrine Disease Treatment Market Analysis

    • 12.1 Southwest China Rare Endocrine Disease Treatment Market, by Type

    • 12.2 Southwest China Rare Endocrine Disease Treatment Market, by Application

    Chapter 13 Northwest China Rare Endocrine Disease Treatment Market Analysis

    • 13.1 Northwest China Rare Endocrine Disease Treatment Market, by Type

    • 13.2 Northwest China Rare Endocrine Disease Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis

        • 14.1.1 Novartis Company Profile

        • 14.1.2 Novartis Rare Endocrine Disease Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Ipsen

        • 14.2.1 Ipsen Company Profile

        • 14.2.2 Ipsen Rare Endocrine Disease Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 EMD Serono

        • 14.3.1 EMD Serono Company Profile

        • 14.3.2 EMD Serono Rare Endocrine Disease Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Corcept Therapeutics

        • 14.4.1 Corcept Therapeutics Company Profile

        • 14.4.2 Corcept Therapeutics Rare Endocrine Disease Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Amgen

        • 14.5.1 Amgen Company Profile

        • 14.5.2 Amgen Rare Endocrine Disease Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Takeda

        • 14.6.1 Takeda Company Profile

        • 14.6.2 Takeda Rare Endocrine Disease Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Eli Lilly

        • 14.7.1 Eli Lilly Company Profile

        • 14.7.2 Eli Lilly Rare Endocrine Disease Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Teva

        • 14.8.1 Teva Company Profile

        • 14.8.2 Teva Rare Endocrine Disease Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novelion Therapeutics

        • 14.9.1 Novelion Therapeutics Company Profile

        • 14.9.2 Novelion Therapeutics Rare Endocrine Disease Treatment Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Rare Endocrine Disease Treatment Industry Research Conclusions

    • 15.2 Rare Endocrine Disease Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Rare Endocrine Disease Treatment Industry Market Size (2018-2029)

    • Figure China Rare Endocrine Disease Treatment Production Volume, Production Value and Growth Rate of Organic Compounds (2018-2029)

    • Figure China Rare Endocrine Disease Treatment Production Volume, Production Value and Growth Rate of Biologics (2018-2029)

    • Figure China Rare Endocrine Disease Treatment Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)

    • Figure China Rare Endocrine Disease Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Rare Endocrine Disease Treatment Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)

    • Figure North China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Rare Endocrine Disease Treatment Market Size and Growth Rate from 2018-2029

    • Figure Rare Endocrine Disease Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Rare Endocrine Disease Treatment Market Share by Type in 2018

    • Figure China Rare Endocrine Disease Treatment Market Share by Type in 2023

    • Figure China Rare Endocrine Disease Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Production Volume and Growth Rate of Organic Compounds (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Production Volume and Growth Rate of Biologics (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Market Share by Application in 2018

    • Figure China Rare Endocrine Disease Treatment Market Share by Application in 2023

    • Figure China Rare Endocrine Disease Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Rare Endocrine Disease Treatment Market Size and Growth Rate of Retail Pharmacies (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Market Size and Growth Rate of Online Pharmacies (2018-2023)

    • Table China Rare Endocrine Disease Treatment Production Volume by Region (2018-2023)

    • Table China Rare Endocrine Disease Treatment Production Volume Share by Region (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Production Volume Share by Region (2018-2023)

    • Table China Rare Endocrine Disease Treatment Production Value by Region (2018-2023)

    • Table China Rare Endocrine Disease Treatment Production Value Share by Region (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Production Value Share by Region (2018-2023)

    • Table China Rare Endocrine Disease Treatment Sales Volume by Region (2018-2023)

    • Table China Rare Endocrine Disease Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Sales Volume Share by Region (2018-2023)

    • Table China Rare Endocrine Disease Treatment Sales Value by Region (2018-2023)

    • Table China Rare Endocrine Disease Treatment Sales Value Share by Region (2018-2023)

    • Figure China Rare Endocrine Disease Treatment Sales Value Share by Region (2018-2023)

    • Table North China Rare Endocrine Disease Treatment Production Volume by Type (2018-2023)

    • Table North China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Table North China Rare Endocrine Disease Treatment Sales Volume by Application (2018-2023)

    • Table North China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Rare Endocrine Disease Treatment Production Volume by Type (2018-2023)

    • Table Central China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Rare Endocrine Disease Treatment Sales Volume by Application (2018-2023)

    • Table Central China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Rare Endocrine Disease Treatment Production Volume by Type (2018-2023)

    • Table South China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Table South China Rare Endocrine Disease Treatment Sales Volume by Application (2018-2023)

    • Table South China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Rare Endocrine Disease Treatment Production Volume by Type (2018-2023)

    • Table East China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Table East China Rare Endocrine Disease Treatment Sales Volume by Application (2018-2023)

    • Table East China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Rare Endocrine Disease Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Rare Endocrine Disease Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Rare Endocrine Disease Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Rare Endocrine Disease Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Rare Endocrine Disease Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Rare Endocrine Disease Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Rare Endocrine Disease Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Rare Endocrine Disease Treatment Sales Volume Share by Application (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Ipsen Company Profile

    • Table Ipsen Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table EMD Serono Company Profile

    • Table EMD Serono Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Corcept Therapeutics Company Profile

    • Table Corcept Therapeutics Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)

    • Table Novelion Therapeutics Company Profile

    • Table Novelion Therapeutics Rare Endocrine Disease Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US